Related Experiment Video
Updated: May 20, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes
Elizabeth R Gilbert1, Dongmin Liu
1Department of Animal and Poultry Sciences, College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA, USA. egilbert@vt.edu
Epigenetic changes, influenced by nutrition, oxidative stress, and inflammation, may drive type 2 diabetes (T2D) by impairing pancreatic beta-cell function. Understanding these mechanisms offers potential therapeutic targets for T2D prevention and treatment.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Type 2 diabetes (T2D) is a global health crisis.
- Insulin resistance, common in obesity and aging, progresses to T2D due to beta-cell dysfunction and apoptosis.
- Environmental and nutritional factors are implicated in T2D pathogenesis, but molecular mechanisms remain unclear.
Purpose of the Study:
- To review emerging knowledge on epigenetic mechanisms in beta-cell dysfunction and T2D.
- To explore the roles of DNA methylation, histone modifications, and miRNA in T2D development.
- To highlight the impact of nutrition, oxidative stress, and inflammation on pancreatic islets.
Main Methods:
- Literature review of recent discoveries in epigenetics and diabetes.
- Focus on DNA methylation and histone modifications.
- Brief review of microRNA (miRNA) effects on pancreatic islets.
Main Results:
- Epigenetic alterations are increasingly recognized as key players in T2D pathogenesis.
- Environmental stimuli like nutrition, oxidative stress, and inflammation can induce epigenetic changes affecting beta-cells.
- These changes can lead to beta-cell dysfunction and apoptosis, contributing to T2D.
Conclusions:
- Epigenetic mechanisms, including DNA methylation and histone modifications, are crucial in beta-cell dysfunction and T2D.
- Understanding these epigenetic regulations may reveal novel therapeutic targets for T2D.
- Further research into gene expression control via epigenetics is vital for diabetes treatment and prevention.
Related Concept Videos
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes I: Introduction
Diabetes Mellitus: Introduction

